封面
市場調查報告書
商品編碼
1535177

植入式輸液接口市場:各市場區隔規模,佔有率,法律規章,償付,手術,2033年為止的預測

Implantable Ports Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

出版日期: | 出版商: GlobalData | 英文 | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

植入式輸液接口,也稱為留置輸液口或皮下輸液口,用於施用化療、藥物、靜脈輸液、營養物質和採集血液樣本。可植入端口是附有一個小儲液器(端口)的導管。端口裝置是為需要長期靜脈注射治療的患者開立的。

癌症,也稱為惡性腫瘤,是細胞的異常生長,可以擴散到身體的其他部位。癌症患者可能需要間歇性化療、腸外營養、靜脈輸液和輸血。

本報告提供全球植入式輸液接口市場相關資料詳細考察,提供市場上競爭情形,SWOT分析,到2033年為止的市場預測,地區,各國的趨勢等資訊。

目錄

已上市的植入式輸液接口和不斷變化的競爭格局

  • 主要的產業趨勢洞察
  • 植入式輸液接口的各市場區隔整體市場收益和2015年~2033年的市場展望
  • 件數,平均銷售價格,市場價值相關詳細資料

世界,地區,各國洞察

  • 植入式輸液接口市場SWOT分析
  • 植入式輸液接口市場相關競爭動態的洞察和趨勢
  • 各國醫療制度概要
  • 各國償付政策
  • 各國醫療技術相關法規狀況
簡介目錄
Product Code: GDME709MM

Implantable Ports Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Drug Delivery Devices therapeutic area.

Implantable ports, also called portacaths or subcutaneous ports, are used to administer chemotherapy, medicine, fluids, and nutrients, or take blood samples. An Implantable Port is a catheter with a small reservoir (port) attached to it. Port devices are prescribed for patients, who require long-term intravenous therapy.

Cancers, also known as malignancies are the abnormal growth of cells which can spread to parts of the body. Oncologic patients may require intermittent administration of chemotherapy, parenteral nutrition, infusions, or blood transfusions.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Implantable Ports and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total Implantable Ports market revenue by segment and market outlooks from 2015-2033.
  • Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Implantable Ports market.
  • Competitive dynamics insights and trends provided for Implantable Ports market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: CR Bard Inc, AngioDynamics Inc, B. Braun Melsungen AG, Teleflex Inc, Vygon SA, A.M.I. GmbH, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Implantable Ports marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
  • Develop business strategies by understanding the trends shaping and driving Implantable ports market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Implantable ports market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Implantable ports market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.